Your browser doesn't support javascript.
loading
Improved glycemic control due to sitagliptin is not related to cortisol or the surrogate marker IGFBP-1 for hepatic insulin sensitivity.
Arnetz, Lisa; Hage, Camilla; Ekberg, Neda Rajamand; Alvarsson, Michael; Brismar, Kerstin; Norhammar, Anna; Mellbin, Linda.
Affiliation
  • Arnetz L; Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital Solna, 17176 Stockholm, Sweden; Dept. of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital Solna, 17176 Stockholm, Sweden. Electronic address: Lisa.Arnetz@karolinska.se.
  • Hage C; Cardiology Unit, Department of Medicine, Karolinska Institutet, 17176 Stockholm, Sweden. Electronic address: camilla.hage@karolinska.se.
  • Ekberg NR; Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital Solna, 17176 Stockholm, Sweden; Dept. of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital Solna, 17176 Stockholm, Sweden. Electronic address: neda.ekberg@ki.se.
  • Alvarsson M; Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital Solna, 17176 Stockholm, Sweden; Dept. of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital Solna, 17176 Stockholm, Sweden. Electronic address: michael.alvarsson@karolinska.se.
  • Brismar K; Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital Solna, 17176 Stockholm, Sweden; Dept. of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital Solna, 17176 Stockholm, Sweden. Electronic address: kerstin.brismar@ki.se.
  • Norhammar A; Cardiology Unit, Department of Medicine, Karolinska Institutet, 17176 Stockholm, Sweden. Electronic address: anna.norhammar@karolinska.se.
  • Mellbin L; Cardiology Unit, Department of Medicine, Karolinska Institutet, 17176 Stockholm, Sweden. Electronic address: linda.mellbin@karolinska.se.
Growth Horm IGF Res ; 25(6): 298-303, 2015 Dec.
Article de En | MEDLINE | ID: mdl-26283275
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Glycémie / Insulinorésistance / Facteur de croissance IGF-I / Hydrocortisone / Intolérance au glucose / Protéine-1 de liaison aux IGF / Diabète de type 2 / Phosphate de sitagliptine / Hypoglycémiants / Foie Type d'étude: Clinical_trials / Diagnostic_studies Limites: Aged / Aged80 / Female / Humans / Male / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Growth Horm IGF Res Sujet du journal: ENDOCRINOLOGIA Année: 2015 Type de document: Article Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Glycémie / Insulinorésistance / Facteur de croissance IGF-I / Hydrocortisone / Intolérance au glucose / Protéine-1 de liaison aux IGF / Diabète de type 2 / Phosphate de sitagliptine / Hypoglycémiants / Foie Type d'étude: Clinical_trials / Diagnostic_studies Limites: Aged / Aged80 / Female / Humans / Male / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Growth Horm IGF Res Sujet du journal: ENDOCRINOLOGIA Année: 2015 Type de document: Article Pays de publication: Royaume-Uni